[Diabetic osteopathy. 4. Laboratory findings]

Area of Science:

• Endocrinology
• Metabolic Bone Disease

Context:

• Diabetes mellitus (Type 1 and Type 2) is a global health concern.
• Bone metabolism is often affected in diabetic patients, leading to increased fracture risk.
• Understanding the specific biochemical markers associated with bone complications in diabetes is crucial.

Purpose:

• To investigate the relationship between diabetes, bone metabolism markers (serum calcium, phosphorus, alkaline phosphatase), and bone mineralization.
• To compare these values across different diabetes types and genders.
• To identify key laboratory indicators influencing bone health in diabetic individuals.

Summary:

• This study examined bone metabolism markers in 38 Type 1 and 222 Type 2 diabetes patients.
• Significantly lower serum calcium and reduced bone mineralization were observed in all diabetic groups, most pronounced in women with Type 2 diabetes.
• Higher alkaline phosphatase activity, particularly the bone isoenzyme, was noted, suggesting potential osteomalacia.
• Bone mineralization was lowest in patients treated with oral antidiabetics, with women exhibiting lower values than men.
• A strong correlation between reduced serum calcium and bone mineralization highlights calcium's critical role in osteoporosis development.

Impact:

• Identifies low serum calcium as a significant risk factor for osteoporosis in diabetic patients.
• Suggests that elevated alkaline phosphatase activity may indicate osteomalacia in this population.
• Provides insights into gender-specific differences in bone metabolism alterations in diabetes.
• Highlights the potential negative impact of oral antidiabetic medications on bone health.